FDA Updates COVID-19 Test Policy; Shifts Focus From EUAs
As part of a policy revamp, the US FDA is encouraging COVID-19 test developers to pursue traditional premarket review pathways rather than emergency use authorizations.
You may also be interested in...
A biodegradable plant-based face mask has won FDA approval for use in healthcare settings, combatting the high amounts of waste generated by pandemic precautions.
AdvaMed’s Scott Whitaker and Michael Minogue outlined the trade group’s legislative goals for the rest of the year, chief among them regulatory oversight for lab-developed tests.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.